China Pharma Holdings, Inc. (CPHI) stock
CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
$0.56+0.02 (+3.09%)
Close on Nov 12, 2026Market cap $24.09MP/E –Yield –
China Pharma operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
China Pharma's operating cash flow for the twelve months ending Jun 30, 2026 was -$140.49K, down 131.1% year over year. For fiscal 2025 it was $148.26K. Over ten years it grew -26.8% a year on average. The highest annual figure on record is $8.60M in fiscal 2013.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $148.26K | – |
| FY2024 | Dec 31, 2024 | -$406.06K | – |
| FY2023 | Dec 31, 2023 | -$699.69K | – |
| FY2022 | Dec 31, 2022 | -$409.55K | – |
| FY2021 | Dec 31, 2021 | -$249.84K | – |
| FY2020 | Dec 31, 2020 | -$42.26K | -106.9% |
| FY2019 | Dec 31, 2019 | $608.31K | -67.7% |
| FY2018 | Dec 31, 2018 | $1.88M | +123.7% |
| FY2017 | Dec 31, 2017 | $841.22K | -70.9% |
| FY2016 | Dec 31, 2016 | $2.90M | -13.6% |
| FY2015 | Dec 31, 2015 | $3.35M | -45.6% |
| FY2014 | Dec 31, 2014 | $6.15M | -28.4% |
| FY2013 | Dec 31, 2013 | $8.60M | +135.9% |
| FY2012 | Dec 31, 2012 | $3.64M | -30.4% |
| FY2011 | Dec 31, 2011 | $5.24M | -32.7% |
| FY2010 | Dec 31, 2010 | $7.79M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$32.83K | -112.0% |
| Q1 FY2026 | Mar 31, 2026 | -$55.29K | – |
| Q4 FY2025 | Dec 31, 2025 | $151.99K | -49.1% |
| Q3 FY2025 | Sep 30, 2025 | -$204.36K | – |
| Q2 FY2025 | Jun 30, 2025 | $274.31K | – |
| Q1 FY2025 | Mar 31, 2025 | -$73.68K | – |
| Q4 FY2024 | Dec 31, 2024 | $298.77K | – |
| Q3 FY2024 | Sep 30, 2024 | -$46.95K | -104.7% |
| Q2 FY2024 | Jun 30, 2024 | -$72.73K | – |
| Q1 FY2024 | Mar 31, 2024 | -$585.16K | – |
| Q4 FY2023 | Dec 31, 2023 | -$22.32K | -103.8% |
| Q3 FY2023 | Sep 30, 2023 | $1.01M | +359.7% |
| Q2 FY2023 | Jun 30, 2023 | -$216.44K | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.47M | – |
| Q4 FY2022 | Dec 31, 2022 | $584.59K | – |
| Q3 FY2022 | Sep 30, 2022 | $219.12K | – |
| Q2 FY2022 | Jun 30, 2022 | -$333.82K | -149.4% |
| Q1 FY2022 | Mar 31, 2022 | -$879.44K | – |
| Q4 FY2021 | Dec 31, 2021 | -$198.11K | -159.2% |
| Q3 FY2021 | Sep 30, 2021 | -$450.85K | – |
| Q2 FY2021 | Jun 30, 2021 | $676.04K | +639.5% |
| Q1 FY2021 | Mar 31, 2021 | -$276.92K | – |
| Q4 FY2020 | Dec 31, 2020 | $334.87K | – |
| Q3 FY2020 | Sep 30, 2020 | -$224.39K | -146.7% |
| Q2 FY2020 | Jun 30, 2020 | $91.42K | -76.4% |
| Q1 FY2020 | Mar 31, 2020 | -$244.16K | – |
| Q4 FY2019 | Dec 31, 2019 | -$22.10K | -102.5% |
| Q3 FY2019 | Sep 30, 2019 | $480.24K | -45.6% |
| Q2 FY2019 | Jun 30, 2019 | $386.63K | – |
| Q1 FY2019 | Mar 31, 2019 | -$236.46K | -145.1% |
| Q4 FY2018 | Dec 31, 2018 | $874.43K | -6.7% |
| Q3 FY2018 | Sep 30, 2018 | $883.29K | +30.3% |
| Q2 FY2018 | Jun 30, 2018 | -$399.34K | – |
| Q1 FY2018 | Mar 31, 2018 | $523.74K | +5264.0% |
| Q4 FY2017 | Dec 31, 2017 | $936.76K | -36.4% |
| Q3 FY2017 | Sep 30, 2017 | $678.03K | -21.8% |
| Q2 FY2017 | Jun 30, 2017 | -$783.34K | – |
| Q1 FY2017 | Mar 31, 2017 | $9.76K | – |
| Q4 FY2016 | Dec 31, 2016 | $1.47M | – |
| Q3 FY2016 | Sep 30, 2016 | $866.84K | – |
See a number that looks wrong?